| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/07/2009 | CN100448431C Oral disintegrated Anfenmame tablet for treating children's cold and its prepn |
| 01/07/2009 | CN100448366C Enzyme preparation and process for producing food using the same |
| 01/06/2009 | US7473796 Maytansinoid intermediates: N-alkyl- or aryldithioalkanoylalanines and N-alkanoyl- or aroylthioalkanoylalanines, e.g., N-methyl-N-(4-methyl-4-methyldithio-1-oxopentyl)-alanine; optical isomers and racemic mixtures; preparations from isobutylene sulfide and acetonitrile, methyl methanethiosulfonate, etc. |
| 01/06/2009 | US7473733 Cationic derivative of a water-soluble polysaccharide, cationic polyvinylalcohol, units derived from acrylic ester complexed with DNA; stable and soap-less latex; useful as a micro carrier for cell cultivation and immuno-adsorbent assay, gene transfer experiments, efficiency, transfection |
| 01/06/2009 | US7473693 pyrazine carboxamide compounds of sub-micron size; improve bioavailibility/absorption, exhibit no increase in size upon storage in the aqueous medium; N-(1-piperidinyl)-5,6-diphenyl-2-pyrazinecarboxamide; using a precipitation process without the need for water-immiscible solvent; obesity |
| 01/06/2009 | US7473682 Angiogenic peptides and uses thereof |
| 01/06/2009 | US7473681 Kahalalide F |
| 01/06/2009 | US7473433 Pulmonary delivery of polyene antifungal agents |
| 01/06/2009 | US7473432 NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery |
| 01/06/2009 | US7473431 Injectable methadone, methadone and naltrexone, or buprenorphine and naltrexone microparticle compositions and their use in reducing consumption of abused substances |
| 01/06/2009 | US7473425 Remedies for ischemic disease |
| 01/06/2009 | US7473416 Medicaments for asthma treatment |
| 01/06/2009 | US7473247 Intradermal delivery of vaccines and gene therapeutic agents via microcannula |
| 01/06/2009 | CA2474838C Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials |
| 01/06/2009 | CA2417630C Novel compositions of minoxidil |
| 01/06/2009 | CA2414737C Pharmaceutical compositions containing tobramycin and xanthan gum |
| 01/06/2009 | CA2395331C Pharmaceutical compositions providing enhanced drug concentrations |
| 01/06/2009 | CA2387058C Injection vehicle for polymer-based formulations |
| 01/06/2009 | CA2348084C Crystallisation using supercritical or subcritical fluids |
| 01/06/2009 | CA2346133C Capsules |
| 01/06/2009 | CA2344470C Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues |
| 01/06/2009 | CA2340238C Improved stability for injection solutions |
| 01/06/2009 | CA2333869C Mousse composition |
| 01/06/2009 | CA2308495C Anaesthetic formulation |
| 01/06/2009 | CA2293575C Controlled release microencapsulated ngf formulation |
| 01/06/2009 | CA2267244C Methods for treating urinary incontinence in mammals |
| 01/06/2009 | CA2264582C Sulfonyl fluorides for the treatment of alzheimer's disease |
| 01/06/2009 | CA2216696C Polysaccharide-bound nitric oxide-nucleophile adducts |
| 01/06/2009 | CA2214778C Process for the production of polymeric microparticles, microparticles that are produced according to this process as well as their use in medical diagnosis |
| 01/06/2009 | CA2194979C Solid drug forms containing clathrates of steroid sex hormones |
| 01/02/2009 | DE102007030434A1 Flüssige Lösungsvermittler enthaltend ethoxylierte Fettalkohole und ethoxylierte Triglyceride Liquid solubilizer containing ethoxylated fatty alcohols and ethoxylated triglycerides |
| 01/01/2009 | US20090005595 Gentisic Acid for Stabilising 123-I Radiopharmaceuticals |
| 01/01/2009 | US20090005463 Liquid solubilizers comprising ethoxylated fatty alcohols and ethoxylated triglycerides |
| 01/01/2009 | US20090005462 Structured depilatory compositions |
| 01/01/2009 | US20090005318 Controlled release composition and method of producing the same |
| 01/01/2009 | US20090005312 Novel glp-1 analogues linked to albumin-like agents |
| 01/01/2009 | US20090004741 Biodegradable polyphosphoramidates for controlled release of bioactive substances |
| 01/01/2009 | US20090004734 Mutated Anti-CD22 Antibodies With Increased Affinity To CD22-Expressing Leukemia Cells |
| 01/01/2009 | US20090004733 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides, and uses thereof |
| 01/01/2009 | US20090004304 Composition comprising bioactive substance |
| 01/01/2009 | US20090004296 Antiseptic Compositions and Methods of Using Same |
| 01/01/2009 | US20090004292 Methods and compositions for deterring abuse of opioid containing dosage forms |
| 01/01/2009 | US20090004286 Compositions for achieving a therapeutic effect in an anatomical structure and methods of using the same |
| 01/01/2009 | US20090004278 Enzymatically Crosslinked Protein Nanoparticles |
| 01/01/2009 | US20090004276 Novel injectable chitosan mixtures forming hydrogels |
| 01/01/2009 | US20090004275 Composition for Delivery of an Active Agent |
| 01/01/2009 | US20090004257 Transdermal administration of fentanyl and analogs thereof |
| 01/01/2009 | US20090004256 Lowly irritative adhesive patch |
| 01/01/2009 | US20090004237 B7-Like Molecules and Uses Thereof |
| 01/01/2009 | US20090004230 Thermosetting Neutralized Chitosan Composition Forming a Hydrogel, Lyophilizate, and Processes for Producing the Same |
| 01/01/2009 | US20090004169 Nucleic Acids For Inhibiting Hairless Protein Expression and Methods of Use Thereof |
| 01/01/2009 | US20090004166 Carrier For Enternal Administration |
| 01/01/2009 | US20090004109 Antibodies and Molecules Derived Therefrom that Bind to Steap-1 Proteins |
| 01/01/2009 | US20090004104 Methods and Compositions for Delivering Active Agents with Enhanced Pharmacological Properties |
| 01/01/2009 | US20090004102 HSC70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
| 12/31/2008 | WO2009003110A2 Metap-2 inhibitor polϋmersomes for therapeutic administration |
| 12/31/2008 | WO2009002768A2 Liquid bandage |
| 12/31/2008 | WO2009002521A2 Compositions of specific binding agents to hepatocyte growth factor |
| 12/31/2008 | WO2009002274A1 Cationic peptide for delivering an agent into a cell |
| 12/31/2008 | WO2009001938A1 Hydrophilic composition containing hinokitiol |
| 12/31/2008 | WO2009001937A1 Hydrophilic composition containing hinokitiol |
| 12/31/2008 | WO2009001899A1 Aqueous composition |
| 12/31/2008 | WO2009001805A1 Novel artificial n-linked sialo-sugar chain-containing polymer and method for producing the same |
| 12/31/2008 | WO2009001787A1 Composition containing coenzyme q10 |
| 12/31/2008 | WO2009001786A1 Composition containing physiologically active substance |
| 12/31/2008 | WO2009001396A1 Disposable sterile ocular solution for corneal cross- linking of cheratocone, and process for production thereof |
| 12/31/2008 | WO2009001219A2 Immunocytokines for cancer treatment in combination with chemotherapeutic agents |
| 12/31/2008 | WO2009001209A1 Use of conjugates of hyaluronic acid in the local treatment of hyperproliferative skin diseases |
| 12/31/2008 | WO2009001163A1 Lyophilized preparations of pantoprazole sodium for injection |
| 12/31/2008 | WO2009000538A1 Trimeric death ligands with enhanced activity (tenascin) |
| 12/31/2008 | WO2009000522A1 Hydrolysable polymeric fmoc-linker |
| 12/31/2008 | WO2009000504A2 Injectable formulation for photodynamic therapy |
| 12/31/2008 | WO2009000146A1 Succinic acid-(5-androsten-17-one-3beta-ol)-diester solid dispersion, method for the production and the use thereof |
| 12/31/2008 | WO2009000132A1 Immediate release effervescent-formulation and preparing process thereof |
| 12/31/2008 | WO2008140507A3 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof |
| 12/31/2008 | WO2008138089A3 Pharmaceutical composition comprising a local anaesthetic and a carboxyvinyl polymer |
| 12/31/2008 | WO2008099742A3 Ejection liquid and ejection method |
| 12/31/2008 | WO2008098151A3 Polar hydrophilic prodrugs of amphetamine and other stimulants and processes for making and using the same |
| 12/31/2008 | WO2008081463A3 Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof |
| 12/31/2008 | WO2008073294A3 Inhibition of angiogenesis and tumor growth by inhibitors of beta ii or delta protein kinase c |
| 12/31/2008 | WO2007119011A9 N protein fusion proteins of a virus in the paramyxoviridae-protein of interest family |
| 12/31/2008 | WO2007119011A8 N protein fusion proteins of a virus in the paramyxoviridae-protein of interest family |
| 12/31/2008 | EP2009022A1 Trimeric death ligands with enhanced activity (tenascin) |
| 12/31/2008 | EP2009018A2 T cell antigen receptor peptides |
| 12/31/2008 | EP2008710A1 Process and apparatus for producing liposome dispersion |
| 12/31/2008 | EP2008666A1 Use of VHH antibodies for the preparation of peptide vectors for delivering a substance of interest and their applications |
| 12/31/2008 | EP2008665A1 Injectable formulation for photodynamic therapy |
| 12/31/2008 | EP2008659A1 Liquid pharmaceutical formulations of palonosetron |
| 12/31/2008 | EP2008650A2 Solid oral composition comprising a S 1 P receptor agonist and a sugar alcohol |
| 12/31/2008 | EP2008649A1 Spill resistant pharmaceutical compositions |
| 12/31/2008 | EP2008532A1 Method for production of capsinoid-containing beverage/food |
| 12/31/2008 | EP2007885A2 Method of increasing the in vivo recovery of therapeutic polypeptides |
| 12/31/2008 | EP2007816A1 Bifunctionalized polysaccharides |
| 12/31/2008 | EP2007811A2 Targeted binding agents directed to upar and uses thereof |
| 12/31/2008 | EP2007801A1 Binder for c-reactive protein |
| 12/31/2008 | EP2007479A2 Solid oral compositions based on s-adenosyl methionine and/or nadh and process for obtaining them |
| 12/31/2008 | EP2007432A1 Biodegradable cationic polymers |
| 12/31/2008 | EP2007431A2 Topical drug delivery |
| 12/31/2008 | EP2007430A2 Ruminant feed composition and method of making |
| 12/31/2008 | EP2007427A2 Improved vaccines comprising multimeric hsp60 peptide carriers |